Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Garcia-Manero

Showing results (1-10 of 1,046) with videos related to

Pageof 105
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Nontransplantation options for patients with myelodysplastic syndromesGuillermo Garcia-Manero
The Lancet. Haematology|October 10, 2022
Current status of phase 3 clinical trials in high-risk myelodysplastic syndromes: pitfalls and recommendationsGuillermo Garcia-Manero
Best Practice & Research. Clinical Haematology|December 4, 2012
Can we improve outcomes in patients with acute myelogenous leukemia? Incorporating HDAC inhibitors into front-line therapyGuillermo Garcia-Manero
Mayo Clinic Proceedings|October 6, 2018
Improving Prognostic Tools for Patients With Myelodysplastic SyndromesGuillermo Garcia-Manero
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentaryGuillermo Garcia-Manero
Current Opinion in Oncology|October 9, 2008
Demethylating agents in myeloid malignanciesGuillermo Garcia-Manero
American Journal of Hematology|August 22, 2015
Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and managementGuillermo Garcia-Manero
Hematology. American Society of Hematology. Education Program|January 18, 2011
Prognosis of myelodysplastic syndromesGuillermo Garcia-Manero
Clinical Advances in Hematology & Oncology : H&O|May 24, 2007
Recent Advances in the Treatment of MDS. A review of selected presentations from the 48th Annual Meeting of the American Society of Hematology, December 9-12, 2006, Orlando, FloridaGuillermo Garcia-Manero
Clinical Advances in Hematology & Oncology : H&O|October 2, 2024
Is luspatercept the new standard of care in transfusion-dependent low-risk myelodysplastic syndromes?Guillermo Garcia-Manero
Pageof 105

Showing results (1-10 of 1,046) with videos related to

Sort By:
Pageof 105
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Nontransplantation options for patients with myelodysplastic syndromesGuillermo Garcia-Manero
The Lancet. Haematology|October 10, 2022
Current status of phase 3 clinical trials in high-risk myelodysplastic syndromes: pitfalls and recommendationsGuillermo Garcia-Manero
Best Practice & Research. Clinical Haematology|December 4, 2012
Can we improve outcomes in patients with acute myelogenous leukemia? Incorporating HDAC inhibitors into front-line therapyGuillermo Garcia-Manero
Mayo Clinic Proceedings|October 6, 2018
Improving Prognostic Tools for Patients With Myelodysplastic SyndromesGuillermo Garcia-Manero
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentaryGuillermo Garcia-Manero
Current Opinion in Oncology|October 9, 2008
Demethylating agents in myeloid malignanciesGuillermo Garcia-Manero
American Journal of Hematology|August 22, 2015
Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and managementGuillermo Garcia-Manero
Hematology. American Society of Hematology. Education Program|January 18, 2011
Prognosis of myelodysplastic syndromesGuillermo Garcia-Manero
Clinical Advances in Hematology & Oncology : H&O|May 24, 2007
Recent Advances in the Treatment of MDS. A review of selected presentations from the 48th Annual Meeting of the American Society of Hematology, December 9-12, 2006, Orlando, FloridaGuillermo Garcia-Manero
Clinical Advances in Hematology & Oncology : H&O|October 2, 2024
Is luspatercept the new standard of care in transfusion-dependent low-risk myelodysplastic syndromes?Guillermo Garcia-Manero
Pageof 105